Skip to product information
1 of 1

SZA LONGEVITY UK

Carrier Screening Test

Carrier Screening Test

Regular price £325.00 GBP
Regular price Sale price £325.00 GBP
Sale Sold out
Taxes included. Shipping calculated at checkout.

Many people carry genetic mutations without showing symptoms. The SZA Longevity Carrier Screening Test identifies whether you carry genes for inherited conditions that could be allowing you to make informed reproductive choices with confidence. If you are a carrier, genetic counselling can help guide your next steps. 

Our comprehensive panel screens for hundreds of genetic conditions, including: 

  • Cystic Fibrosis
  • Spinal Muscular Atrophy (SMA)
  • Sickle Cell Anaemia 
  • Tay-Sachs Disease
  • Fragile X Syndrome
View full details

Why Carrier Screening Matters

1 in 4

Couples Carry the Same Genetic Condition.

+

1

%

of Individuals Are Carriers of At Least One Condition.

~

1

%

of Rare Diseases have a genetic basis - According to UK's Rare Diseases Action Plan.

1 in 100

Couples in the UK are at risk of having a child affected by a serious recessive condition.

This test is highly recommended for

Individuals or couples planning to start a family

People from ethnic backgrounds with a higher risk of specific genetic disorders

Anyone seeking proactive, genetics-based health insights

Those with a family history of inherited genetic conditions

Individuals or couples planning to start a family

People from ethnic backgrounds with a higher risk of specific genetic disorders

Anyone seeking proactive, genetics-based health insights

Those with a family history of inherited genetic conditions

Scope of Analysis: Comprehensive Carrier Screening Test

Core Gene Panel Coverage

Analysis of key inherited conditions including cystic fibrosis, spinal muscular atrophy (SMA), Fragile X syndrome, and congenital bilateral absence of the vas deferens (CBAVD).

Expanded Panel Options

Broader screening that includes over 200 additional genes associated with inherited disorders such as cystinosis, Smith-Lemli-Opitz syndrome, Krabbe disease, Zellweger syndrome, and spinal cerebellar ataxias.

Haemoglobinopathies & Blood Disorders

Identification of gene variants linked to beta-thalassemia, alpha-thalassemia, sickle cell anaemia, and glucose-6-phosphate dehydrogenase (G6PD) deficiency.

Neuromuscular & Developmental Disorders

Screening for Duchenne muscular dystrophy, Becker muscular dystrophy, Rett syndrome, ataxia-telangiectasia, and spinal muscular atrophy (SMA).

Ethnicity-Specific Conditions*

Inclusion of conditions with higher prevalence in specific populations: Tay-Sachs disease, Canavan disease, Gaucher disease, Bloom syndrome, Niemann-Pick disease type A, familial dysautonomia, Fanconi anaemia (Ashkenazi Jewish); beta-thalassemia (Mediterranean); sickle cell anaemia (African); and G6PD deficiency (Southeast Asian and Middle Eastern).

*Some genetic conditions are more prevalent in specific ethnic populations due to carrier frequency patterns observed in global genomic studies.

X-linked & Recessive Inheritance Mapping

Classification of each condition based on mode of inheritance, including autosomal recessive conditions, autosomal dominant conditions, and X-linked conditions such as ornithine transcarbamylase (OTC) deficiency, hemophilia A and B, and X-linked SCID.

Variant Detection & Classification

Identification of pathogenic, likely pathogenic, and variants of uncertain significance (VUS) using global guidelines and curated variant databases.

Risk Pairing for Partners

Combined carrier risk interpretation when both partners are tested, supporting informed reproductive decisions when both are carriers of the same condition.

What’s Included in Your Carrier Screening Report

Summary of Your Carrier Status

A concise overview indicating whether any carrier variants were identified and their relevance to reproductive risk.

A concise overview indicating whether any carrier variants were identified and their relevance to reproductive risk.

Gene and Variant Details

Specific information about the gene(s) where a variant was found, including the type of mutation and classification (e.g. pathogenic, likely pathogenic).

Specific information about the gene(s) where a variant was found, including the type of mutation and classification (e.g. pathogenic, likely pathogenic).

Condition-Specific Findings

For each condition tested (e.g. cystic fibrosis, SMA, Fragile X), results are presented clearly with inheritance patterns and potential implications.

For each condition tested (e.g. cystic fibrosis, SMA, Fragile X), results are presented clearly with inheritance patterns and potential implications.

Inheritance Pattern Explanation

Each condition includes a visual or written explanation of whether it follows an autosomal recessive, X-linked, or dominant inheritance model.

Each condition includes a visual or written explanation of whether it follows an autosomal recessive, X-linked, or dominant inheritance model.

Ethnicity-Based Risk Context

Interpretation of your results in the context of your reported ethnic background, especially where certain variants are more prevalent.

Interpretation of your results in the context of your reported ethnic background, especially where certain variants are more prevalent.

Partner Screening Recommendations

If you are identified as a carrier, the report will outline whether partner or donor testing is advised.

If you are identified as a carrier, the report will outline whether partner or donor testing is advised.

Residual Risk Explanation

A brief note explaining the remaining chance of being a carrier even if your result is negative, based on current technology limits.

A brief note explaining the remaining chance of being a carrier even if your result is negative, based on current technology limits.

Glossary and Scientific Notes

Definitions and explanations of key genetic terms and variant classifications to help you better understand your results.

Definitions and explanations of key genetic terms and variant classifications to help you better understand your results.

Next Steps and Optional Counselling

Clear guidance on whether further action is recommended, including the option for genetic counselling or clinical consultation.

Clear guidance on whether further action is recommended, including the option for genetic counselling or clinical consultation.

How it works: steps after purchasing

Step 1

Download the app and log in

Once you complete your purchase, a unique barcode is automatically generated for you—so there’s no need to activate it manually. You’ll receive a confirmation email along with your personalised app profile. Simply download the app, activate your account, and we’ll notify you as soon as your results are ready.

step 2

Collect your sample

Collect your stool sample discreetly at home using the provided kit and return it to us free of charge. Test-specific instructions are included inside the package. If you have any questions at any point, feel free to contact our support team.

step 3

Receive your results

Pair text with an image to focus on your chosen product, collection, or blog post. Add details on availability, style, or even provide a review.

Frequently Asked Questions

What is the SZA Longevity Carrier Screening Test?

Our Carrier Screening Test is a comprehensive genetic test that identifies whether you carry genetic variants that could be passed on to your children. While carriers are typically healthy, they can unknowingly pass on serious inherited conditions. This test helps individuals and couples make informed decisions about family planning by identifying their risk for transmitting genetic disorders.

How does the test work?

  1. Collect a saliva sample using the swab in your test kit.
  2. Send your sample back to our certified lab following the detailed instructions.
  3. Our team performs a high-resolution genetic analysis to detect carrier status for hundreds of inherited conditions.
  4. You will receive a personalized report within 2 weeks in the SZA Longevity App. If needed, you can book a consultation with one of our experts for further support and guidance.

Who should take this test?

This test is recommended for:

  • Individuals or couples planning to have children
  • People with a family history of genetic conditions
  • Individuals from populations with higher carrier risk for specific conditions (e.g., Ashkenazi Jews, Mediterranean African, Southeast Asian descent.)

What are the benefits?

  • Gain clarity about your carrier status for hundreds of inherited conditions.
  • Make informed family planning decisions with the help of expert insights.
  • Reduce the risk of passing on serious genetic conditions to future children.
  • Access expert support through optional consultations for understanding and next steps.
  • Feel empowered with personalized, preventative genetic information.

How common are these conditions?

While individual genetic conditions are rare, collectively they are more common than many realise. Around 1 in 30 couples is at increased risk of having a child affected by a genetic condition​.

Will this tell me anything about my own health?

The test is designed to assess reproductive risk. In rare cases, certain gene variants may have implications for your own health, but this is uncommon. Any relevant findings are explained with medical support.

Can I rely on family history instead?

Not entirely. Most people who carry a genetic condition have no family history of it. Genetic screening can reveal hidden risks that family history alone cannot detect.

If I already know a condition runs in my family, should I still do this?

Yes. Even if you're aware of a specific condition, this test can screen for additional inherited conditions you may not know about.

Can I take this alongside other pregnancy tests like NIPT?

Yes. Carrier screening can be done alongside chromosome testing (like NIPT), but they serve different purposes. NIPT looks at chromosome conditions, while carrier screening looks at inherited single-gene variants.

How do I order the test? Do I need a doctor?

The test can be ordered online and completed at home. You don’t need a doctor to access the test, but our medical team is available to support you and involve your healthcare provider if needed.

What happens if my results indicate a higher risk?

SZA Longevity provides tools to help you access and understand personal health data, but we are not a diagnostic entity and do not provide medical advice. If your results suggest a higher genetic risk, we can arrange a consultation with a qualified healthcare professional or genetic counsellor who can guide you through your options and next steps.

How accurate is the test?

Our tests are processed in accredited laboratories using validated methods and high-quality sequencing technology. While no test can guarantee 100% accuracy, the results are reliable for identifying genetic variants associated with carrier status. Any findings should be discussed with a healthcare professional for appropriate interpretation and follow-up.

How will I receive my results?

Once your sample has been processed, your results will be made available through our secure online platform. You’ll receive an email notification when they’re ready. If further support is needed, we can help you arrange a consultation with a qualified professional to review your results in detail.